In this work, a cost-effective and simple-to-prepare label-free electrochemical immunosensor was, for the first time, fabricated by modifying high-quality graphene oxide (GPO) onto a screen-printed carbon electrode (SPCE). The anti-IgG antibody was then covalently immobilized to the carboxylic group anchoring on the surface of GPO particles. Under the optimized condition, our newly developed immunosensor selectively bound to human immunoglobulin G (IgG), a model biomarker, with high sensitivity at a limit of detection of 1.99 ng mL -1 , potentially sensitive enough for IgG detection at the pathophysiological level, and had a linear range of 2.5 to 100 ng mL -1 . The proposed immunosensor also exhibited high reproducibility and regenerability, resulting in no significant change in electrochemical signals from different replicates of the electrode, and a robust electrochemical current after being subjected to alkaline base washing with several cycles. To this end, our immunosensor demonstrates ability as a promising diagnostic tool for clinical assessment.
Introduction
Immunoglobulins (Igs) play a crucial role as biochemical mediators in the adaptive immune system as a defensive mechanism in our body. In particular, they fight against invading pathogens by recognizing bacteria and viruses, resulting in activating complex downstream signalling cascades for immune response. 1 There are five types of Igs (IgA, IgM, IgE, IgG and IgD) in human plasma; the IgG level presented in body fluids is considered to be highest among the other types of Igs, 2 since it is capable of carrying out all of the functions of Ig molecules. 3, 4 In terms of clinical practice, IgG is not only used for disease diagnosis, but also for therapeutic use, where 150 antibodies are currently being developed for clinical applications, and 14 Igs have been approved for therapy. 5 Recently, IgG has been markedly realized as a potential biomarker for several types of diseases, including cancers, 6 Alzheimer's disease, 7 inflammatory bowel disease, 8 and autoimmune disease. 9 Resulting from the crucial role played by IgG as well as the sensitivity and selectivity resulting from the high affinity binding of the Ig to the antigen, significant efforts have been put into developing immunoassays for IgG detection, such as radioimmunoassay, enzyme-linked immunosorbent assay (ELISA), 10 chemiluminescence immunoassays, 11 surface plasmon resonance (SPR), 12 and label-free immunoassay based on an organic field-effect transistor. 13 However, these methods are time-consuming, expensive and require highly trained persons to operate. By contrast, electrochemical immunosensors provide an alternative analytical tool for IgG detection in that the method is highly sensitive, selective, cost-effective and simple to use. [14] [15] [16] For this reason, immunosensors developed from electrochemical techniques have become increasingly popular.
To fabricate electrochemical immunosensors, much attention has been drawn to the use of graphene oxide (GPO) due to its special structure and properties.
The oxygen-containing functional groups in GPO render hydrophilicity that results in better dispersibility in water than graphene, 17 leading to easier GPO deposition on the electrode surface. 18 Second, those oxygen-containing functional groups including alcohol, epoxide, and carboxylic acid on the surface of GPO can be chemically engineered to ameliorate GPO properties with nanoparticles, organic compounds, conducting polymers and biomolecules either via covalent or non-covalent modification. 19 Third, GPO offers a high specific surface area 20 and excellent electrochemical properties by readily accommodating electron transfer at the electrode surface. 21 As a result of the striking properties of GPO, an electrochemical immunosensor was constructed by modifying GPO on SPCE. Exploiting the oxygenated groups for constructing an antibodyimmobilizing platform, the anti-IgG antibody was covalently attached onto the surface of the electrode using amide coupling chemistry for IgG detection. In this work, no secondary antibody is needed to amplify the signal; thus, an economical and easy-to-prepare label-free immunosensor was obtained. Then, different types of parameters affecting the sensitivity of the electrochemical immunosensor were optimized, such as the pH, incubation times of the antibody and the antigen. This gave rise to a high sensitivity of IgG detection (as low as 1.99 ng mL -1 ), while preventing the anti-IgG antibody from denaturation at physiological pH. To meet the requirement for running samples multiple times, 22 our electroanalytical platform shows a regenerable capability after being washed with a low concentrated alkaline base solution, together with reproducible electrochemical signals after being tested with different replicates of the electrode. To the best of our knowledge, we are the first to develop a label-free immunosensor for IgG detection with a simple and inexpensive preparation along with high sensitivity, multiple regenerability, good reproducibility and high specificity to the human IgG via immunocomplex interaction.
Experimental

Chemicals and solutions
All chemicals used in this study were of analytical grade and used as received. A GPO powder was prepared by a modified Hummer's method 23 with a triple-exfoliation process developed in our laboratory, where KMnO4 was equally added three times into the reactor (stirred for 1 h each) to exfoliate GPO from the graphite particle. In our case, the process was developed in our laboratory. Due to unreacted KMnO4 in the reactor from the first addition, The second time of KMnO4 addition was replaced by adding a small amount of water (10% of total solution volume) to produce heat and the exfoliation occurred again. Graphite (SP-1, Michigan) was purchased from Bay Carbon Inc., USA.
Human IgG in human serum, potassium hexacyanoferrate(II) trihydrate (K4[Fe(CN)6]·3H2O), and antiIgG antibody were purchased from Sigma-Aldrich, USA. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) were ordered from Merck, Germany. Bovine serum albumin (BSA) was obtained from Merck, Germany. Sodium hydroxide (NaOH), potassium hexacyanoferrate(III) (K3[Fe(CN)6]), potassium chloride (KCl) and potassium nitrate (KNO3) were purchased from Lab Scan, Poland.
Carbon ink (Acheson Electrodag PR-406) was purchased from Henkel, USA. Disodium hydrogen phosphate dehydrate (Na2HPO4·2H2O) was purchased from Scharlau, Spain and sodium hydrogen phosphate dehydrate (NaH2PO4·2H2O) was purchased from Merck, Germany. Sodium chloride (NaCl) was received from Carlo Erba, Italy. Interleukin-15 (IL-15) and dopamine from Sigma-Aldrich (USA), uric acid (UA) from Hopkins&Wiliams, ascorbic acid (AA) from Merck (Germany) and Glucose (Glu) from Fluka (Switzerland) were ordered. All aqueous solutions were prepared using deionized water; 5.0 mM NaOH and phosphate buffer saline (PBS) containing 5.0 mM [Fe(CN)6] 4-/3-(1:1 molar ratio) were prepared and used for regeneration of the electrode surface and sensing tests, respectively. Further, 0.4 M EDC and 0.1 M NHS solutions were prepared and mixed freshly at the ratio of 1:1. Phosphate buffers with various pHs were prepared at a concentration of 0.01 M. A blocking solution, 0.5%(w/v) BSA, was prepared in a PBS buffer. Solutions of all biomolecules were prepared employing PBS.
Apparatus
Voltammetric measurements, including cyclic and differential pulse voltammetries, were performed on an Autolab type II Potentiostat/Galvanostat (Metrohm, Netherlands) controlled by the GPES program. A conventional three-electrode cell, including a Ag/AgCl (3 M NaCl) electrode as the reference electrode, a Pt electrode as the counter electrode and an screenprinted carbon electrode (SPCE) (0.1256 cm 2 area) as the working electrode, was employed.
Preparation of the bioelectrodes
The in-house working electrodes were screen-printed on a PVC substrate using carbon ink. The screen-printed carbon patterns were heated at 150 C in an oven (G-therm 075, Fratelli Galli, Italy) for 1 h, and then the screen printing process was repeated once. The electrodes were treated with a plasma cleaner (PDC-32G, Harrick Plasma, USA) for further use. The electrodes, except for the working area, were covered with nail varnish before use. Treated SPCEs were modified with 2 μL of GPO dispersion in water, and dried at ambient temperature two times. The electrodes were activated with 20 μL of an EDC/NHS (1:1) solution for 30 min, and then incubated with 20 μL of the anti-IgG solution in a refrigerator (4 C). As a result, immunoelectrodes for the detection of IgG were obtained (Fig. S1 , Supporting Information). The unreacted sites were blocked using 20 μL of the BSA solution for 30 min. To obtain the best analytical response, the optimized concentration of anti-IgG on the electrode surface with timing incubation of antibody and antigen solutions, respectively, was studied in terms of good recognition. The prepared immunoelectrodes were stored in a refrigerator (4 C).
Procedure
All electrodes were electrochemically characterized employing the [Fe(CN)6] 4-/3-reaction (1:1 molar ratio). The immunosensor was constructed with a three-electrode cell using the immunoelectrode as a working electrode. Firstly, the differential pulse voltammetric (DPV) signal of the [Fe(CN)6] 4-/3-process at the immunoelectrode was recorded to obtain a baseline response. The DPV condition used was performed with a potential step of 5 mV, a modulation amplitude of 50 mV, a modulation time of 20 ms and a scan rate of 10 mV/s. The analytical responses obtained from the immunosensor were evaluated based on the differences of the DPV currents before and after immunoreactions occurring by incubation of the working electrode in a 20-μL drop of the standard IgG solutions at different concentrations. To obtain the signal, after incubation in the IgG solution, the electrode was washed with PBS buffer (pH 7.4), followed by recording the DPV of the redox reaction. It was then soaked in 20 μL of a 5.0 mM NaOH solution for 5 min, and subsequently washed with PBS buffer (pH 7.4) to carry out regeneration of its surface. For making the calibration curve, this cycle of the analytical signal generation with a decrement of the IgG concentration was repeated several times. To perform the best signal, pH, loading of anti-IgG antibody, and incubation periods for immobilization of the anti-IgG and for immunoreaction of IgG on the electrode surface were optimized. The steps of the immobilization, immunoreaction, and regeneration were carried out at a temperature of 4 C, while the electrochemical measurements were undertaken at ambient temperature. To find the optimal pH, GPO-modified SPCE ([GPO] = 1.0 mg mL -1 ) was incubated with 20 μL of an anti-IgG solution at a concentration of 20 μg mL -1 for 30 min to measure the current and potential at different pHs. To examine the optimal concentration of anti-IgG (20 -100 μg mL -1 ), an incubation time of 30 min and a pH of 7.4 were employed. To investigate the optimal incubation time of anti-IgG (10 -60 min), the concentration of anti-IgG (80 μg mL -1 ) and pH 7.4 were used. In addition, to determine the complete immunoreaction time, an IgG antigen concentration of 50 ng mL Finally, an interference study was performed by the incubation of each interference solution in order to examine any non-specific adsorption and the effect of the oxidation current of the adsorbed interference molecules.
Results and Discussion
Determination of optimum GPO concentration
To determine the level of GPO used to modify on SPCE, the differential pulse voltammetric (DPV) technique was employed to measure the current at different concentrations of GPO (0.5 -5 mg mL -1 ). By monitoring the DPV signal derived from the redox process of [Fe(CN)6] 4-/3-, the current is increased and reaches the maximum current intensity when the concentration of GPO is 1.0 mg mL -1 (Fig. 1) . When further increasing the concentration of GPO, the signal is decreased and remains constant regardless of the increased concentration of GPO ([GPO] > 3.0 mg mL -1 ). The decrease of the current is probably due to the conglomeration of GPO. The thicker GPO film slows electron transfer on GPO-deposited SPCE, caused by the long distance of electron transfer and restriction by nonconductive part (deconjugated by oxygenic group of the GPO). According to the enhancement of the electroreactivity before reaching 3.0 mg mL -1 GPO, it is indicated that the GPO used in our work is of high quality; whereas, GPO was generally expected to be used in high quantity due to its low conductivity caused by the oxygenic groups that restrict the electron transfer. 21 For example, the amount of GPO used in this work is similar to that of reduced GPO, a material being 4 orders of magnitude higher in conductivity than GPO, 24 employed by Fakhari et al. to fabricate SPCE for detecting Buprenorphine. 25 
Mechanistic determination of electron transfer
To test whether the electron-transfer mechanism of the [Fe(CN)6] 4-/3-process at the electrode is diffusion-limited, cyclic voltammetry (CV) was used to measure the current at different scan rates, ranging from 10 to 100 mV/s ( 4-/3-on the electrode surface is diffusion-controlled.
Optimization of the electroanalytical bioplatform
The pH of the buffer is one of the most important factors in the optimization of electrochemical parameters, since it affects the conformation of proteins, which in turn affects molecular recognition 26 and gives rise to different electrochemical signals. The sensitivity of the immunosensor also immensely relies on the concentration and the incubation time of anti-IgG immobilized on the electrode, as well as the time of human IgG allowed for the immunocomplex to form at the surface of the sensor. Consequently, these parameters need to be optimized. To obtain an optimum pH, a series of buffer solutions with pH ranging from 6.0 to 8.0 was prepared. As shown in Fig. 2a , the electrochemical signals incrementally increase according to the elevation of the buffer pH, and give rise to the highest response at pH 7.4. However, they reach the plateau when the pH is further increased (pH 8.0). The observed maximum response stems from the native conformation that most proteins assume at the physiological pH (7.4). 26 In agreement with many reports, 27-29 the redox potentials are slightly shifted to lower values at higher pH (Fig. 2a) , because the potential depends on the ionic strength, 29 the parameter that was shown as a function of the pH. 30 It was shown that if pH is shifted one unit from 9.00 to 10.00 at the equal concentration of the buffer system, the potential is changed by 5 mV. 29 After that, the concentrations of the anti-IgG antibody immobilized on the sensor were varied from 20 -100 μg mL -1 in order to obtain the optimal concentration during immobilization. Depicted in Fig. 2b , the constant current starts when the concentration of anti-IgG antibody is 80 μg mL -1 , which is adopted as the optimal concentration. The constant value of the current is probably caused by a deterioration of the electrode surface from the agglomeration of the high concentration of the anti-IgG antibody. 31 Later on, the anti-IgG antibody at a concentration of 80 μg mL -1 is allowed for immobilization on the electrode with different time points, at which the lowest electrochemical signal is observed at 30 min, and remains constant afterwards (Fig. 2c) . At this time point, the surface of the electrode is saturated with the anti-IgG antibody, which yields reliable, consistent and repeatable electrochemical signals. The reduction of the current is due to a blockage of the redox process [Fe(CN)6] 4-/3-at the surface from the readily anchored anti-IgG antibody. In this case, the incubation time of the anti-IgG antibody at 30 min was adopted for this sensor. Finally, the temporal profile of human IgG binding was investigated by incubation on anti-IgG antibody electrochemical platform for 10 to 60 min. As shown in Fig. 2d , the intensity of the current decreased and started to reach the plateau at 30 min, reflecting the saturation binding of human IgG onto the anti-IgG antibody. Therefore, these following experimental parameters are being used in further experiments: controlled pH 7.4 for maintaining native conformation of anti-IgG antibody, optimal concentration of anti-IgG antibody at 80 μg mL -1 as well as optimal incubation times of anti-IgG antibody and human IgG at 30 min are adopted for yielding the highest electrochemical response.
Linearity and sensitivity
The analytical features of the binding reaction of human IgG to the electrode-immobilized anti-IgG antibody were evaluated using the DPV technique. As shown in Fig. 3a , the reduction of the peak current is observed, as oppose to the increased concentration of human IgG due to the degree of the restriction of the redox process of the ferro/ferricyanide system. The use of anti-IgG antibody serves as a negative control and the immunosensor yields the highest intensity (Fig. 3a) . The observed current is systematically decreased with the increased concentration of human IgG (Fig. 3a) . When plotted, the difference in the reduction of the current against the concentration of human IgG (Fig. 3b) , the calibration curve responds linearly (r 2 = 0.995) from 2.5 to 100 ng mL -1 , with a low limit of detection of 1.99 ng mL -1 . The sensitivity obtained from the immunosensor is 1.7445 μA mL ng -1 cm -2 (Fig. 3b) . This high sensitivity is attributed to two major factors: GPO and anti-IgG antibody. GPO offers a high surface-to-volume ratio; 20 thus, the transducing area of the electrode is increased, yielding a better limit of detection. Additionally, anti-IgG binds specifically and tightly to the analyte IgG with the association constant at 10 8 to 10 9 M -1 ; 32 therefore, a better recognition event and a better limit of detection of the sensor are obtained. Moreover, loading of the antibodies essentially affects the detection limit due to an elevation of the immunoreaction. In our experiment, we optimized the highest loading while varying the concentration of anti-IgG and the incubation time, giving the highest lowering in the DPV current, which indicated a high loading of antibodies on the electrode surface. In addition to good sensitivity, a simple preparation process is adopted in our developed sensor because we exploit the simplicity of the label-free technique along with the use of low-cost SPCE, particularly, when compared to other immunosensors, as shown in Table 1 . For instance, the immunosensors developed in entry 1 -3 [33] [34] [35] (Table 1) show an ≈ 5 -15 fold higher in detection limit than that constructed in our work (entry 7), even though those immunosensors (entry 1 -3) are prepared by more complicated procedures where precious metals (i.e., gold and silver) and more expensive materials are used in devising the immunosensors. In addition, the immunosensor in entry 4, 36 constructed for acetaminophen detection that is prepared in a similar fashion to that in entry 7, exhibits an ≈ 13-fold higher value in the limit of detection than does our developed immunosensor. This obviously indicates that our electroanalytical platform is highly efficient in human IgG detection. Moreover, the sensitivity of our newly developed immunosensor has a limit of detection as low as that in entry 5, 37 which is complicatedly elaborated with gold nanoparticle-colloid carbon spheres on a glassy carbon electrode (GCE). In contrast with GCE, our immunosensor is also disposable due to the very low cost of GPO sitting on SPCE. The DNA nanopyramid biosensor shown in entry 6 38 displays a much higher sensitivity than does our sensor in entry 7; however, this electroanalytical platform is difficult and costly to prepare for human IgG detection due to its complicated architecture, suggesting the inapplicability of this sensor in clinical practice. To this end, the low limit of detection of our developed immunosensor is promisingly applicable for human IgG detection in the blood from patients with autoimmune disease, and those infected with pathogenic bacteria, because the concentration of human IgG under the normal physiological condition was observed in the range of 8.30 -18.20 mg mL -1 for healthy Turkish children. 39 
Selectivity
In addition to linearity and sensitivity of central importance to the development of biosensors are selectivity, reproducibility and regenerability, about which the last two parameters will be discussed later on. To assess whether the immunosensor specifically binds to human IgG, the electrode is challenged with the high concentration of different types of inferences including interleukin-15 (IL-15), uric acid (UA), ascorbic acid (AA), dopamine (DA) and glucose (Glu) (Fig. 4) , whose nonspecific adsorption on the electrode surface or surface coverage would be unable to restrict the redox process of the ferro/ ferricyanide system significantly. Moreover, no significant contribution of the oxidation currents of common redox interferences adsorbed on the surface was observed. This result indicates that the sensor selectively binds to human IgG by showing an approximately 16-fold higher signal intensity relative to those derived from binding with the interferences at a 40-fold higher concentration. This strongly suggests the practical applicability of the developed immunosensor for further analysis in biological samples.
Reproducibility and regenerability
The reproducibility of the sensor was also evaluated by measuring the electrochemical signal from eight different electrodes. The current signals derived from those electrodes are not significantly different, clearly suggesting the good reproducibility of the immunosensor (Fig. S3, Supporting  Information) . The reusability was tested by measuring the peak current from the immunocomplex formation between human IgG and anti-IgG antibody after washing with the alkaline solution for six cycles. As shown in Fig. 5 , the current was increased when the immunosensor was unoccupied by IgG after alkaline washing, and decreased when being subject to binding to IgG, with no significant difference of the signals in those six cycles of the alkaline washing. As a result, the surface of the immunoelectrode is regenerable, obtaining a good baseline stability of the device and reusability.
Conclusions
In this work, we achieved in developing an electrochemical immunosensor using label-free human IgG detection based on the easy-to-prepare GPO-modified SPCE. The two coupling agents, EDC and NHS, were used for anchoring of the anti-IgG antibody onto the electrode surface for selectively sensing human IgG. The fabricated electrode was then optimized for the purpose of obtaining high efficiency of the immunosensor, with several parameters, including the pH of the buffer, incubation time and concentration of the anti-IgG antibody covalently immobilized on the electrode surface as well as the amount of time allowed for human IgG to form the immunocomplex onto the anti-IgG. The immunosensor shows a linear response in the range of 2.5 -100 ng mL -1 human IgG, along with a low limit of detection of 1.99 ng mL -1 . In addition, the sensor exhibits high selectivity towards human IgG when challenged with a 40-fold higher concentration of the interferences. To this end, our newly developed immunosensor shows strong potential for further development as a sensor for non-invasively sampling of human IgG in clinical practice.
